UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of CD19 and CD22 CAR‐T cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation

American journal of hematology, 2021-06, Vol.96 (6), p.671-679

2021

Volltextzugriff (PDF)

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Journal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1089-1099

2021

Volltextzugriff (PDF)

Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7028-7028

2022

Volltextzugriff (PDF)

Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients: An Informative Approach to Optimize Manufacturing Strategies

Blood, 2023-11, Vol.142 (Supplement 1), p.3513-3513

2023

Volltextzugriff (PDF)

The petrographical and isotope geochemical tracers for deep ore-forming fluids from the Laowangzhai gold depoist in the northern part of the Ailao Mountains

Acta geochimica, 2013-09, Vol.32 (3), p.281-294

2013

Volltextzugriff (PDF)

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

Blood, 2020-06, Vol.135 (26), p.2425-2427

2020

Volltextzugriff (PDF)

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2023-04, Vol.58 (4), p.440-442

2023

Volltextzugriff (PDF)

Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7035-7035

2022

Volltextzugriff (PDF)

Assessment of Activities of Daily Living (ADL)Scale Can be Used to Predict Overall Survival after CAR-T Cell Therapy in Elderly Patient(over 70 years of age) with Refractory/Relapsed B-Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.6922-6922

2023

Volltextzugriff (PDF)

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

Blood, 2023-11, Vol.142 (Supplement 1), p.6943-6943

2023

Volltextzugriff (PDF)

Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.557-557

2021

Volltextzugriff (PDF)

Exploring the Efficiency and Survival of CAR T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities

Blood, 2022-11, Vol.140 (Supplement 1), p.7548-7549

2022

Volltextzugriff (PDF)

Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy

Blood, 2022-11, Vol.140 (Supplement 1), p.10384-10385

2022

Volltextzugriff (PDF)

Efficacy and Safety of Donor-Derived CD7 CAR T Cells for r/r T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Interim Analysis from a Phase 2 Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.4602-4603

2022

Volltextzugriff (PDF)

Donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10001-10001

2021

Volltextzugriff (PDF)

Updated efficacy and safety report of a phase I trial of donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7023-7023

2022

Volltextzugriff (PDF)

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

The lancet oncology, 2023-11, Vol.24 (11), p.1229-1241

2023

Volltextzugriff (PDF)

Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.657-657

2021

Volltextzugriff (PDF)

Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Nature medicine, 2024-10

2024

Volltextzugriff (PDF)

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial

Molecular therapy, 2024-09

2024

Volltextzugriff (PDF)

Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement

Blood, 2021-11, Vol.138 (Supplement 1), p.257-257

2021

Volltextzugriff (PDF)

Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology

The journal of obstetrics and gynaecology research, 2010-12, Vol.36 (6), p.1195-1203

2010

Volltextzugriff (PDF)

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.2126-2126

2018

Volltextzugriff (PDF)

The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma

Journal of oncology, 2022, Vol.2022, p.2900310-20

2022

Volltextzugriff (PDF)

Osteopontin Expression in Human Decidua is Associated with Decidual Natural Killer Cells Recruitment and Regulated by Progesterone

In vivo (Athens), 2008-01, Vol.22 (1), p.55-61

2008

Volltextzugriff (PDF)

26 – 50 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(68)

Sprache

Englisch
(67)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Humans
(27)
Life Sciences & Biomedicine
(27)
Female
(17)
Oncology
(16)
Hematology
(13)
Child
(12)
Adult
(11)
Immunotherapy, Adoptive - Adverse Effects
(10)
Lymphocytes T
(10)
Male
(9)
Leukemia
(8)
Lymphocytes
(8)
Patients
(8)
Remission
(8)
Adolescent
(7)
Antigens
(7)
Cd19 Antigen
(7)
Child, Preschool
(7)
Neurotoxicity
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Combination of CD19 and CD22 CAR‐T cell therapy in relapsed B‐cell acute lymphoblastic leukemia after allogeneic transplantation

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia

Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients: An Informative Approach to Optimize Manufacturing Strategies

The petrographical and isotope geochemical tracers for deep ore-forming fluids from the Laowangzhai gold depoist in the northern part of the Ailao Mountains

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma

Autologous CD7-targeted CAR T-cell therapy for refractory or relapsed T-cell acute lymphoblastic leukemia/lymphoma

Assessment of Activities of Daily Living (ADL)Scale Can be Used to Predict Overall Survival after CAR-T Cell Therapy in Elderly Patient(over 70 years of age) with Refractory/Relapsed B-Cell Lymphoma

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Including Donor Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma

Exploring the Efficiency and Survival of CAR T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities

Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy

Efficacy and Safety of Donor-Derived CD7 CAR T Cells for r/r T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Interim Analysis from a Phase 2 Trial

Donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia

Updated efficacy and safety report of a phase I trial of donor-derived CD7 CAR T cells for T-cell acute lymphoblastic leukemia

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy

Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial

Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement

Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma

Osteopontin Expression in Human Decidua is Associated with Decidual Natural Killer Cells Recruitment and Regulated by Progesterone

Suchergebnisse filtern